News from halt medical, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 16, 2014, 08:50 ET
Acessa Procedure Logo 2013.

Halt Medical, Inc. Announces BlueCross & BlueShield of IL, TX, OK, NM and MT Issue Positive Coverage Decisions for the Acessa™ Procedure for Women with Symptomatic Fibroids

 Halt Medical, Inc. announced today that BlueCross & BlueShield of Illinois, Texas, Montana, New Mexico and Oklahoma, part of Health Care...

Jun 03, 2014, 10:45 ET
Acessa Procedure Logo 2013.  (PRNewsFoto/Halt Medical, Inc.)

Halt Medical, Inc. Announces Aetna US Healthcare and Coventry Health Care Positive Coverage Decision for the Acessa™ Procedure for Women with Symptomatic Fibroids

 Halt Medical, Inc., today announced that Aetna US Healthcare and Coventry Health Care have published updates to their Fibroid Treatment...

May 09, 2014, 13:37 ET
Acessa Procedure Logo 2013.  (PRNewsFoto/Halt Medical, Inc.)

Halt Medical Announces FDA Clearance of the Acessa Guidance Hand Piece for Treatment of Symptomatic Uterine Fibroids

Halt Medical, a medical device innovator focused on establishing a new standard of care for women with symptomatic uterine fibroids, today...

Dec 02, 2013, 16:34 ET
Acessa Procedure Logo 2013.  (PRNewsFoto/Halt Medical, Inc.)

Halt Medical Announces CMS Assignment of Ambulatory Payment Classification for RF Ablation of Uterine Fibroids

 Halt Medical is pleased to announce that the Centers for Medicare and Medicaid Services (CMS) has established a new Ambulatory Payment...

Nov 12, 2013, 08:10 ET

New Data Show that Women with Uterine Fibroids Experienced Significant and Long-Term Improvement in Their Symptoms with the Acessa™ Procedure

Halt Medical today announced that data from a large multi-center clinical study of the Acessa™ Procedure showed that women with uterine...

Aug 21, 2013, 03:00 ET

Halt Medical, Inc. Announces That Brigham and Women's Faulkner Hospital is First New England Provider of the Acessa™ Procedure

 Halt Medical, Inc. announced today that Brigham and Women's Faulkner Hospital is the first hospital in New England to treat patients with the...

Jul 25, 2013, 03:00 ET

The Fibroid Treatment Collaborative Adopts Acessa™ Procedure as First Line Surgical Therapy for Uterine Fibroids

 The Fibroid Treatment Collaborative, with centers in Chicago, IL and Austin TX, announced today the adoption of the Acessa Procedure as its...

Jul 11, 2013, 03:00 ET

Forest Park Medical Center, Dr. Alan Greenberg and Halt Medical Collaborate on Breakthrough Therapy for Patients with Uterine Fibroids

 Forest Park Medical Center Frisco, part of the Dallas-based physician-owned hospital system dedicated to providing unsurpassed surgical care,...

Jul 10, 2013, 03:00 ET

Halt Medical Announces New CPT® Code From the American Medical Association for RF Ablation of Uterine Fibroids

 Halt Medical is very pleased to announce that the American Medical Association (AMA) Current Procedure Terminology (CPT) Panel has established...

Jun 25, 2013, 03:00 ET

The Acessa™ System Wins Gold in the 15th Annual Medical Design Excellence Awards Competition

Halt Medical, Inc. is proud to announce that the Acessa System was awarded Gold in the radiological and electromechanical devices category at the...

Apr 01, 2013, 03:00 ET

Halt Medical Announces Initial Commercial Results; Expanded Launch of Acessa™ System

Halt Medical, Inc. announced today initial commercialization results for the Acessa System and additional launch plans. "We are grateful and...

Mar 12, 2013, 03:00 ET

Halt Medical Announces The First Commercial Use Of the Acessa™ System

Halt Medical, Inc. announced that Dr. Jay M. Berman, M.D., FACOG, has performed the first commercial Acessa Procedure in the United States. The...

Feb 11, 2013, 03:00 ET

The Acessa™ System Now Approved In Mexico To Treat Symptomatic Uterine Fibroids

Halt Medical, Inc. announced today that on January 18, 2013, COFEPRIS, a division within the Mexican Ministry of Health (Secretaria de Salud)...

Jan 09, 2013, 03:00 ET

Halt Medical Introduces Team To Commercialize Acessa™ System For The Treatment Of Uterine Fibroids

 Halt Medical, Inc. introduced today a team to drive commercialization of the Acessa System, a newly FDA cleared medical device to treat...

Jan 02, 2013, 03:00 ET
Treat all the fibroids - just the fibroids.  (PRNewsFoto/Halt Medical, Inc.)

Halt Medical Announces Financing To Support Commercialization Of Newly FDA Cleared Medical Device To Treat Uterine Fibroids

 Halt Medical, Inc. announced today that it has received $15 million of financing to support commercialization of the Acessa™ System, a...

Nov 06, 2012, 11:00 ET

Acessa™ by Halt Medical receives FDA approval for treating uterine fibroids

 Halt Medical, Inc. announced today at the opening session of the AAGL Global Congress on Minimally Invasive Gynecology that the FDA has...

Feb 11, 2012, 06:00 ET

Halt Medical, Inc. Closes on First $20 Million of a $50 Million Financing

 Halt Medical, Inc. announced today that it has closed on the first $20 million of a planned $50 million debt and equity financing. ...

Dec 20, 2010, 10:15 ET

Halt Medical Presents Strong Results of International Fibroid Studies at National Institutes of Health Global Congress

Women suffering from uterine fibroids, a debilitating condition that affects more than seven million women in the U.S., may soon have reason for...

Oct 18, 2010, 17:47 ET

Halt Medical Receives Canadian License for Fibroid Treatment Device

Halt Medical, Inc. announced today that it has been approved to market the Tulip™ Radiofrequency Volumetric Thermal Ablation (RFVTA) probe in...

Jul 26, 2010, 08:00 ET

Dr. Robert J. Rubin to Join Halt Board as Reimbursement Advisor

Halt Medical, Inc. announced today that Robert J. Rubin, M.D. has been appointed to its Scientific Advisory Board.  Dr. Rubin will also be a...